Nutriband (NTRB) announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of August 10 until October 27 , Co-Founder and Chairman, Serguei Melnik had taken over the responsibilities of CEO. Mr Sheridan has returned to the position of CEO effective immediately and will guide the company through the final 2025 framework towards the target NDA filing in 2026 for AVERSA Fentanyl.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRB:
- Nutriband signs agreement with Brand Institute to develop brand for patch
- Nutriband files provisional patent application for AVERSA technology
- Oracle surges on cloud outlook, Novo to cut 9,000 jobs: Morning Buzz
- Nutriband reports Q2 EPS ($2.12) vs. (15c) last year
- Nutriband Issues Shares Amid Investor Engagement